Adorem Plus

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adorem Plus

Quick Facts

Property Description
Active Ingredients Acetaminophen, Caffeine
Form Oral tablet or caplet
Pharmacological Class Combined analgesic, Antipyretic, CNS stimulant (Adjuvant)
Common Use Relief of pain and fever
Origin Synthetic chemical compound combination

What Type of Medicine is Adorem Plus? (Classification and Identity)

Adorem Plus is classified as a fixed-dose combination (FDC) product belonging to the combined analgesic and antipyretic pharmacological class. It is fundamentally a non-opioid analgesic-antipyretic agent formulated for oral administration. Acetaminophen is widely used for its analgesic and antipyretic properties, making it a foundation for such symptomatic relief preparations. This type of medicine works to help manage both general aches and fever.

The structure of Adorem Plus as an FDC places it in a category of products that combine active agents, a therapeutic approach clinically recognized for its efficiency in treating symptoms such as headache and mild muscle aches. This combination structure is designed to provide targeted relief, distinguishing it from single-agent formulations.

Composition and Synergistic Purpose

Adorem Plus contains two primary active ingredients: Acetaminophen (Paracetamol) and Caffeine, delivered in a solid oral formulation. This composition is a mix of two synthetic chemical compounds, with Acetaminophen serving as the core agent for managing pain and temperature. Caffeine, a xanthine derivative, is included as an analgesic adjuvant and mild Central Nervous System (CNS) stimulant.

The general purpose of this dual-action formulation is to provide targeted, enhanced relief. The addition of Caffeine can significantly enhance the pain-relieving effects of an analgesic like Acetaminophen. The caffeine component helps boost the pain-fighting ability of the main medicine. This synergistic effect involves the two agents working together to address both physical discomfort and elevated body temperature efficiently, addressing a typical use scenario like relief from general malaise associated with the common cold.

What side effects are possible with Adorem Plus?

Possible Side Effects and Safety Information

The safety profile for Adorem Plus, a combination of Acetaminophen and Caffeine, is defined by the officially documented risks associated with each active component. Regulatory documents categorize adverse reactions primarily by frequency and the body's organ systems involved.

Frequency and System-Organ Classes

The most frequently observed adverse reactions are generally linked to the stimulating effects of the Caffeine component. These effects are often classified as Common and include nervousness, insomnia, and various forms of gastrointestinal discomfort. Less common effects may include palpitations and dizziness.

The system-organ classes involved, as noted in regulatory labeling, include Hepatobiliary disorders, Nervous system disorders, Psychiatric disorders, and Cardiac disorders.

Serious and Regulatory Constraints

Serious adverse reactions, though typically classified as Rare or Very Rare, are explicitly documented in official labeling. The most critical risk is Acute Liver Failure, associated with cumulative dose or overdose of Acetaminophen. Other serious documented risks include Severe Cutaneous Adverse Reactions (SCARs) and severe allergic responses.

Regulatory safety constraints emphasize the need to avoid concomitant use with any other product containing Acetaminophen to prevent exceeding the maximum daily limit. Furthermore, official documents note that the risk of Medication-Overuse Headache (MOH) is associated with the chronic, high-frequency use of analgesic combinations.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory overdose profile for Adorem Plus addresses the distinct risks of its active components. Documented overdose presentations commonly include early, non-specific signs such as nausea, vomiting, and malaise. Later or high-dose exposure may lead to tachycardia, tremor, agitation, and abdominal pain. The physiological systems officially documented as affected are the Hepatic System, with the risk of necrosis and acute liver failure, and the Central Nervous System, with potential excitation and seizures.

The most severe outcome classified in regulatory documents is Acute Liver Failure. Due to this risk, official emergency-response statements mandate that any suspected overdose requires the patient to seek immediate medical attention, even if symptoms are not yet apparent. Immediate hospitalization is required for comprehensive toxicological assessment.

Official overdose statements confirm that N-acetylcysteine (NAC) is the specific antidote for Acetaminophen toxicity, and its use is guided by the measurement of plasma Acetaminophen concentrations. Increased susceptibility to severe hepatotoxicity is explicitly noted for populations with pre-existing hepatic impairment or a history of chronic alcohol use.

Regulatory documents define the overdose profile through the combined threat of delayed hepatic injury and acute CNS effects. This dual-risk structure determines the mandatory requirement for urgent attention to initiate the time-sensitive antidote protocol.

Therapeutic Uses of Adorem Plus

What Adorem Plus Treats: Main Uses and Benefits

Adorem Plus is authorized for providing symptomatic relief across a range of conditions. Its primary use is in addressing acute manifestations associated with certain inflammatory and non-inflammatory states, as well as providing support for discomfort related to musculoskeletal conditions, joint pain, and headache. It offers a targeted approach to reduce discomfort and supports comfort during the recovery period.

The medicine's benefits extend to supporting individuals dealing with chronic symptoms across specific clinical domains. By addressing key discomfort indicators, it aids in improving the quality of life and functional capacity for those with long-standing issues. This approach may support more consistent participation in daily activities.


“Adorem Plus helps to manage symptom severity, with the aim of supporting greater ease in pursuing a daily routine.”

Key Use

Key Use: Supports relief of acute discomfort in inflammatory and non-inflammatory states.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Adorem Plus

Official regulatory documents define strict criteria for the appropriate use of Adorem Plus (Acetaminophen/Caffeine), establishing populations who are eligible, restricted, or prohibited from using the medicine.

Eligibility Scope
Populations for whom use is allowed (as stated in label): Adults and Adolescents typically 12 years of age and older.
Populations for whom use is contraindicated: Patients with a documented known hypersensitivity or allergy to Acetaminophen, Caffeine, or any component of the formulation; individuals with a history of severe skin reactions (e.g., SJS, TEN, AGEP) to Acetaminophen; patients with severe active liver disease or severe hepatic impairment.
Populations for whom use is not recommended: Children under 12 years of age (use not established for the combination); patients who are pregnant or breastfeeding due to potential risks from the caffeine component.

Eligibility-Related Restrictions
Conditional Use (Caution Required): Use must be with caution in patients with pre-existing liver disease, severe renal impairment, or those who consume ge 3 alcoholic drinks daily, due to the officially documented risk of liver toxicity from the Acetaminophen component.
Co-Exposure Restriction: Users must not use any other product containing Acetaminophen concurrently, as this increases the risk of severe liver damage, a major regulatory constraint.

Official eligibility statements: Regulatory documents classify use in certain groups as contraindicated (e.g., severe liver disease) or requiring caution (e.g., existing renal impairment). These classifications strictly enforce the official boundaries for who can and cannot use the medicine.

What should I know about interactions with other medicines?

Adorem Plus's regulatory interaction profile is primarily defined by constraints related to the metabolism and systemic exposure of its active components, Acetaminophen and Caffeine.

Prohibited Co-administration and Substance Restrictions

A formal prohibition exists against the co-administration of Adorem Plus with any other prescription or over-the-counter product containing acetaminophen. This mandate is in place to mitigate the risk of exceeding the maximum daily dose and subsequent severe hepatic injury. Furthermore, the use of Adorem Plus carries a critical regulatory warning concerning concomitant ethanol/alcohol consumption. Use while consuming three or more alcoholic drinks per day significantly increases the risk of hepatotoxicity associated with the acetaminophen component. The intake of external caffeine-containing beverages or foods should also be limited to prevent additive central nervous system stimulant effects from the product's caffeine component.

Documented Medication Interactions

The acetaminophen component engages in officially documented interactions with other medicines. This includes a pharmacodynamic interaction with oral anticoagulants (e.g., Warfarin), which may potentiate the anticoagulant effect and result in an increase in the International Normalized Ratio (INR), requiring close surveillance. Caution is also warranted during co-administration with inducers of hepatic microsomal enzymes (e.g., Carbamazepine) due to a pharmacokinetic interaction that may increase the potential for hepatotoxicity. The severity of these risks is heightened in patient populations with underlying liver disease or a history of chronic alcoholism.

Mechanism of Action

Adorem Plus acts through multiple central nervous system targets to modulate neuronal signaling. The compound functions as an antagonist at several subunits of the N-methyl-D-aspartate (NMDA) receptor, specifically NMDA 1, 2D, 3A, and 3B. This antagonism results in a concentration-dependent blockade of the ionotropic glutamate receptor, thereby reducing excitatory neurotransmission and downstream intracellular calcium influx within postsynaptic neurons. Concurrently, the molecule serves as an antagonist at the Histamine H1 receptor, which dampens histaminergic signaling pathways. Adorem Plus also acts as an inhibitor of the Sodium-dependent Noradrenaline Transporter (NET). The inhibition of NET reduces the neuronal reuptake of norepinephrine, leading to increased intrasynaptic concentrations of the neurotransmitter. These collective molecular interactions, particularly the NMDA receptor antagonism and NET inhibition, modulate overall central nervous system electrical activity, influencing both somatomotor and limbic pathways. The compound also exhibits an inhibitory interaction with Sodium channel protein type 10 subunit alpha.

Dosage and Administration Information

Adorem Plus is intended for oral administration and is used on an as-needed (PRN) basis rather than a fixed daily schedule. Standard instructions establish a precise use protocol by setting strict limits on both the total number of units taken and the maximum daily intake of the Acetaminophen component.

The standard regimen involves taking one or two units every 4 hours. However, the total daily intake must not exceed 6 capsules or tablets in a 24-hour period. Furthermore, the total dose of Acetaminophen from all sources, including Adorem Plus, must be strictly limited to 4000 milligrams (4 grams) per day.


Administration Guidelines Summary

Entity Official Instruction
Route of Administration Oral (by mouth).
Frequency Pattern As-needed, with a minimum interval of 4 hours between doses.
Duration Constraint Use the lowest effective dosage for the shortest duration possible; extended use is not advised.
Concurrent Use Must not be taken with any other product containing Acetaminophen.

The medicine is not established for use in patients younger than 12 years of age. For older adults, dose selection must be cautious, typically starting at the lower end of the established range. If using a liquid formulation, a calibrated measuring device must be used for accurate dosing. If the medication has been taken regularly and is being discontinued, a gradual dose tapering may be required.

Recent Clinical Evidence

Research evidence / Overview of studies for Adorem Plus

Research for Adorem Plus has explored outcomes related to physical discomfort and temporary elevated body temperature. Evidence has been derived mainly from controlled human trials and scientific reviews. This overview summarizes the structure of the existing research without offering individual predictions or clinical recommendations.


Evidence for use in Acute Headache

This section will summarize the structure of Randomized Controlled Trials (RCTs) and Systematic Reviews that examined the combination related to acute headache, including the specific pain relief outcomes measured and the adult populations studied.

The research exploring short-term symptom changes in acute headache has utilized numerous short-term, single-dose Randomized Controlled Trials (RCTs). These studies were designed to measure changes in pain intensity and the number of participants reporting specific levels of outcomes related to physical discomfort over a limited timeframe. Findings describe patterns observed in the studies where the combination was associated with more participants reporting specific changes in perceived discomfort compared to the placebo comparator.


Evidence for use in Acute General Pain

This block outlines the evidence base, primarily focusing on single-dose RCTs conducted in standardized pain models, such as post-operative dental pain, and discusses the Total Pain Relief and Pain Intensity Difference measures researchers used.

Some trials described patterns where the combination reported higher measured scores on symptom intensity difference scales compared to single-agent Acetaminophen in certain acute pain models. However, certainty remains low for some aspects, as findings related to the contribution of the second agent in non-headache pain models were reported as mixed or variable across different studies.


Evidence for Antipyresis (Fever Reduction)

Research examined outcomes related to systemic imbalance, specifically measuring the change in elevated body temperature from the baseline. Findings describe patterns observed in these studies where administration of the antipyretic component was associated with specific changes in elevated body temperature. The specific role or independent contribution of the Caffeine component to the antipyretic effect is not fully established as a primary outcome in the core evidence base.


What is Still Uncertain About Adorem Plus Research

Follow-up durations were limited in many primary efficacy studies, providing context for episodic changes but not sustained management. Long-term effects are not fully established, and there is limited information available for outcomes related to repeated or extended use of the combination. Data for certain groups, such as children and older adults, remains insufficient compared to the primary adult cohorts.

Key Studies & References

  1. Acetaminophen/Aspirin/Caffeine - StatPearls (NIH)
  2. Acetaminophen - StatPearls (NIH)

Frequently Asked Questions (FAQ)

Common questions about Adorem Plus (FAQ)


Q: Is Adorem Plus the same as [Competitor Drug Name]?

A: Adorem Plus is classified as a fixed-dose combination (FDC) product that contains two active ingredients: Acetaminophen and Caffeine. Regulatory documents define its identity based on this dual composition, distinguishing it from single-ingredient formulations.


Q: Is it okay to drink coffee or caffeine while taking Adorem Plus?

A: Regulatory documents advise limiting your intake of external caffeine from sources like coffee, tea, and certain foods while using this medicine. Because Adorem Plus already contains Caffeine, this limitation helps to avoid consuming excessive amounts of the stimulant, which may cause nervousness, irritability, sleeplessness, or a rapid heartbeat.


Q: What happens when Adorem Plus is taken with alcohol?

A: Official labeling includes a warning that combining this medicine with alcohol is associated with a significantly increased risk of severe hepatic injury, or liver damage. This risk is specifically highlighted for patients who consume three or more alcoholic drinks per day due to the acetaminophen component in the formulation.


Q: What are the official clinical expectations for Adorem Plus outcomes?

A: Clinical studies reviewed in official documents have examined the combination’s association with specific changes in perceived discomfort and elevated body temperature outcomes compared to a placebo. The official expectations are summarized from these research findings.


Q: Does Adorem Plus have a warning label about mental health effects?

A: Official regulatory documents list Psychiatric disorders and Nervous system disorders as system-organ classes that are involved in documented adverse reactions. Less common effects that have been reported include nervousness and insomnia.


Q: Can Adorem Plus be used by people with kidney issues?

A: The use of this medicine requires caution in patients who have severe renal impairment (kidney issues). Official documents advise that the effects of therapy in these patients should be monitored with serial renal function tests.


Q: Is Adorem Plus a controlled substance?

A: The Acetaminophen and Caffeine combination product is not designated as a federally controlled substance according to official regulatory classification bodies.


Q: Are there any specific foods I should avoid while on Adorem Plus?

A: Regulatory information specifically advises limiting the intake of caffeine-containing beverages and foods due to the medicine's caffeine component. This limitation helps to avoid consuming excessive amounts of the stimulant.


Q: Is Adorem Plus safe for long-term use?

A: Official documents state that extended use is not advised, and that the long-term effects are not fully established. Chronic, high-frequency use is also associated with the risk of developing a Medication-Overuse Headache (MOH).


Q: Is Adorem Plus approved for use in children?

A: The combination has not been established for use in patients younger than 12 years of age, according to the information provided in official regulatory documents regarding pediatric use.


Q: Why is Adorem Plus sometimes preferred over other treatment options?

A: The formulation is a fixed-dose combination (FDC) that includes Caffeine as an analgesic adjuvant. This adjuvant is described in research as helping to enhance the pain-relieving effects of the core analgesic component, Acetaminophen.


Q: Can I stop taking Adorem Plus suddenly?

A: For patients who have been taking the medicine regularly, regulatory documents indicate that a gradual dose tapering may be required upon discontinuation. Tapering is generally recommended to manage discontinuation effects.


Q: Is it normal to feel a bit dizzy when starting Adorem Plus?

A: Dizziness is listed in regulatory documents as a less common or infrequent adverse reaction that has been reported. It is a documented effect that is classified as less common.


Q: Are there any warnings about Adorem Plus and driving?

A: Official labeling cautions that tasks requiring mental and physical abilities, such as driving a car or operating machinery, may be impaired by this medicine. Official documents advise that users should assess their own reaction before performing hazardous tasks.


Q: Does Adorem Plus cause changes in blood pressure?

A: Due to the presence of the Caffeine component, regulatory documents describe that central nervous system stimulants may cause an increase in heart rate and blood pressure. This is a potential cardiovascular effect associated with the stimulant.


Q: Is the tiredness felt during the first week of Adorem Plus normal?

A: Fatigue, or tiredness, is listed in regulatory documents as an infrequent or less common adverse reaction that has been reported by users. It is a documented effect that is classified as less common.


Q: Does Adorem Plus require any specific tests before starting treatment?

A: Regulatory documents state that for patients with pre-existing severe hepatic (liver) or renal (kidney) disease, the effects of therapy should be monitored with serial liver and/or renal function tests.


Q: What is the risk of allergic reaction to Adorem Plus?

A: Serious reactions, including Severe Cutaneous Adverse Reactions (SCARs) and severe allergic responses, are explicitly documented in official labeling. While SCARs are classified as rare, a risk of allergic reaction is present.


Q: Why do some people need to stop taking Adorem Plus?

A: Official documents list absolute contraindications (reasons why the medicine must not be used), such as severe active liver disease or a known hypersensitivity/allergy. Users may also be advised to stop taking the medicine due to the occurrence of documented adverse reactions.


Q: Is Adorem Plus known to interact with birth control pills?

A: Evidence suggests that oral contraceptives may have a minor effect on the metabolism of the acetaminophen component. However, concurrent administration at usual therapeutic dosages is generally described as resulting in no significant additional risk.


Q: What is the expected duration of treatment with Adorem Plus?

A: For over-the-counter use, official guidance advises against using the product for pain lasting longer than 10 days or for a fever lasting more than 3 days. The medicine is intended for short-term, as-needed use.


Q: Are there any specific warnings for people with heart conditions using Adorem Plus?

A: The stimulant component requires caution, as official documents note that many central nervous system stimulants are contraindicated in patients with significant cardiovascular impairment or severe hypertension.


Q: Is Adorem Plus available in different strengths or forms?

A: The medicine is primarily supplied in an oral tablet or caplet form. Official documents also describe the availability of different component strengths and certain liquid formulations.


Q: Is the benefit of Adorem Plus supported by long-term data?

A: Official research documents note that follow-up durations were limited in many primary efficacy studies. Therefore, regulatory documents state that the long-term effects are not fully established for this combination.


Q: Does Adorem Plus have a recognized effect on mood?

A: Regulatory documents list Psychiatric disorders as a system-organ class involved in adverse reactions. Reported side effects include excitement and nervousness, which may affect mood.


Q: Are there any specific patient monitoring requirements for Adorem Plus?

A: Official documents state that patients with severe hepatic or renal disease should be monitored with serial function tests. Additionally, due to the stimulant component, patients should be monitored for potential tachycardia (fast heart rate) and hypertension (high blood pressure).


How should Adorem Plus be stored and disposed of?

How to Store and Dispose of Adorem Plus?

The storage of Adorem Plus is governed by regulatory requirements to ensure product stability and safety.

Official Storage Conditions

The medication must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from excess heat and moisture; therefore, storing it in areas like the bathroom is prohibited. To maintain integrity, keep the medicine in its original container with the cap tightly closed. The product must always be stored out of the sight and reach of children.

Labeled Disposal Rules

To dispose of unused or expired Adorem Plus, the official guidance directs using a drug take-back program or mail-back envelope where available. As an alternative, the medicine should be mixed with an unappealing substance, placed in a sealed bag, and discarded with household trash. Do not flush the medication down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adorem Plus found in:

A-Z Index: